Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.400
-0.020 (-1.41%)
At close: Dec 5, 2025, 4:00 PM EST
1.380
-0.020 (-1.43%)
After-hours: Dec 5, 2025, 7:30 PM EST
Lexicon Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 49.66 | 66.66 | 22.47 | 46.35 | 64.07 | 126.26 | Upgrade
|
| Short-Term Investments | 66.29 | 171.3 | 147.56 | 92.01 | 22.68 | 26.01 | Upgrade
|
| Cash & Short-Term Investments | 115.95 | 237.96 | 170.03 | 138.36 | 86.74 | 152.28 | Upgrade
|
| Cash Growth | -55.12% | 39.95% | 22.89% | 59.50% | -43.04% | -43.95% | Upgrade
|
| Receivables | 2.33 | 3.47 | 1.01 | 0.03 | 0.01 | 0.4 | Upgrade
|
| Inventory | 0.16 | 0.23 | 0.38 | - | - | - | Upgrade
|
| Prepaid Expenses | 4.09 | 4.53 | 5.13 | 2.48 | 2.16 | 5.05 | Upgrade
|
| Total Current Assets | 122.53 | 246.19 | 176.55 | 140.87 | 88.92 | 157.72 | Upgrade
|
| Property, Plant & Equipment | 9.49 | 7.32 | 7.51 | 8.48 | 3.45 | 1.53 | Upgrade
|
| Goodwill | 44.54 | 44.54 | 44.54 | 44.54 | 44.54 | 44.54 | Upgrade
|
| Other Long-Term Assets | 29.37 | 0.37 | 0.83 | 0.41 | - | - | Upgrade
|
| Total Assets | 205.93 | 298.42 | 229.43 | 194.3 | 136.91 | 203.79 | Upgrade
|
| Accounts Payable | 3.8 | 14.8 | 14.39 | 10.4 | 9.15 | 5.47 | Upgrade
|
| Accrued Expenses | 11.98 | 29.27 | 15.87 | 11.49 | 11.88 | 29.14 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 11.65 | Upgrade
|
| Current Portion of Leases | 1.64 | 1.18 | 1.29 | 1.29 | 1.09 | 0.55 | Upgrade
|
| Current Unearned Revenue | 4.3 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 21.72 | 45.25 | 31.55 | 23.17 | 22.12 | 46.81 | Upgrade
|
| Long-Term Debt | 56.51 | 100.3 | 99.51 | 48.58 | - | - | Upgrade
|
| Long-Term Leases | 6.8 | 4.6 | 5.27 | 5.42 | 1.19 | 0.61 | Upgrade
|
| Other Long-Term Liabilities | 0.74 | 2.32 | - | - | - | - | Upgrade
|
| Total Liabilities | 85.77 | 152.47 | 136.32 | 77.18 | 23.31 | 47.42 | Upgrade
|
| Common Stock | 0.37 | 0.36 | 0.25 | 0.19 | 0.15 | 0.14 | Upgrade
|
| Additional Paid-In Capital | 2,127 | 2,117 | 1,863 | 1,709 | 1,609 | 1,561 | Upgrade
|
| Retained Earnings | -2,002 | -1,967 | -1,767 | -1,590 | -1,488 | -1,400 | Upgrade
|
| Treasury Stock | -5.19 | -4.62 | -2.89 | -2.06 | -7.52 | -4.84 | Upgrade
|
| Comprehensive Income & Other | 0.03 | 0.12 | 0.03 | -0.43 | -0.01 | -0.01 | Upgrade
|
| Shareholders' Equity | 120.16 | 145.95 | 93.11 | 117.12 | 113.6 | 156.37 | Upgrade
|
| Total Liabilities & Equity | 205.93 | 298.42 | 229.43 | 194.3 | 136.91 | 203.79 | Upgrade
|
| Total Debt | 64.95 | 106.07 | 106.06 | 55.29 | 2.28 | 12.81 | Upgrade
|
| Net Cash (Debt) | 51 | 131.88 | 63.96 | 83.06 | 84.46 | 139.47 | Upgrade
|
| Net Cash Growth | -66.56% | 106.19% | -23.00% | -1.66% | -39.44% | 461.88% | Upgrade
|
| Net Cash Per Share | 0.14 | 0.41 | 0.29 | 0.50 | 0.58 | 1.26 | Upgrade
|
| Filing Date Shares Outstanding | 363.4 | 361.49 | 246.24 | 188.73 | 149.59 | 143.56 | Upgrade
|
| Total Common Shares Outstanding | 363.4 | 361.49 | 244.92 | 188.73 | 148.92 | 141.5 | Upgrade
|
| Working Capital | 100.81 | 200.95 | 145 | 117.69 | 66.8 | 110.91 | Upgrade
|
| Book Value Per Share | 0.33 | 0.40 | 0.38 | 0.62 | 0.76 | 1.11 | Upgrade
|
| Tangible Book Value | 75.62 | 101.41 | 48.57 | 72.58 | 69.05 | 111.83 | Upgrade
|
| Tangible Book Value Per Share | 0.21 | 0.28 | 0.20 | 0.38 | 0.46 | 0.79 | Upgrade
|
| Machinery | 2.39 | 2.39 | 4.35 | 4 | 4.72 | 5.69 | Upgrade
|
| Leasehold Improvements | 2.18 | 2.18 | 2.18 | 2.05 | 1.31 | 0.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.